Marinus Pharmaceuticals Stock Market Value
| MRNS Stock | USD 0.32 0.01 3.03% |
| Symbol | Marinus |
Marinus Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Marinus Pharmaceuticals. If investors know Marinus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Marinus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.47) | Revenue Per Share 0.539 | Quarterly Revenue Growth 0.325 | Return On Assets (0.58) | Return On Equity (29.87) |
The market value of Marinus Pharmaceuticals is measured differently than its book value, which is the value of Marinus that is recorded on the company's balance sheet. Investors also form their own opinion of Marinus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Marinus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Marinus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Marinus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Marinus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Marinus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marinus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Marinus Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Marinus Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Marinus Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Marinus Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Marinus Pharmaceuticals or generate 0.0% return on investment in Marinus Pharmaceuticals over 30 days. Marinus Pharmaceuticals is related to or competes with Akero Therapeutics, Terns Pharmaceuticals, Madrigal Pharmaceuticals, Inozyme Pharma, Viking Therapeutics, 89bio, and Cabaletta Bio. Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for pa... More
Marinus Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Marinus Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Marinus Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 98.81 | |||
| Value At Risk | (9.76) | |||
| Potential Upside | 10.34 |
Marinus Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Marinus Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Marinus Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Marinus Pharmaceuticals historical prices to predict the future Marinus Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (2.47) | |||
| Treynor Ratio | (0.29) |
Marinus Pharmaceuticals Backtested Returns
Marinus Pharmaceuticals has Sharpe Ratio of -0.0508, which conveys that the firm had a -0.0508% return per unit of risk over the last 3 months. Marinus Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Marinus Pharmaceuticals' Mean Deviation of 5.86, standard deviation of 12.56, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.67, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Marinus Pharmaceuticals will likely underperform. At this point, Marinus Pharmaceuticals has a negative expected return of -0.65%. Please make sure to verify Marinus Pharmaceuticals' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if Marinus Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.13 |
Insignificant predictability
Marinus Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Marinus Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Marinus Pharmaceuticals price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Marinus Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | 0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Marinus Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Marinus Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Marinus Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Marinus Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Marinus Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Marinus Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Marinus Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Marinus Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Marinus Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Marinus Pharmaceuticals Lagged Returns
When evaluating Marinus Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Marinus Pharmaceuticals stock have on its future price. Marinus Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Marinus Pharmaceuticals autocorrelation shows the relationship between Marinus Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Marinus Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Marinus Stock Analysis
When running Marinus Pharmaceuticals' price analysis, check to measure Marinus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marinus Pharmaceuticals is operating at the current time. Most of Marinus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Marinus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marinus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Marinus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.